Investing News Network
- Top 5 Canadian Silver Stocks in 2026 (2026-04-01)
Silver achieved a triple-digit price in the first quarter of 2026, drawing attention to silver-mining companies.
During January, the silver price reached an all-time high of US$121.62 per ounce. Although prices have come down significantly in recent weeks, silver remains well above its 40 year previous high of around US$50.
The price of the precious metal has seen firm support from fundamentals — the white metal continues to experience a structural supply deficit, supported by robust industrial silver demand.
Investment demand is also rising as silver offers a more affordable safe-haven alternative to gold.
How has silver's price movement benefited Canadian silver stocks on the TSX, TSXV and CSE?
The five companies below have seen the best performances year-to-date. Data was gathered using TradingView's stock screener on March 25, 2026, and all companies listed had market caps over C$10 million at that time.
1. BP Silver (TSXV:BPAG)
Year-to-date gain: 56.25 percent
Market cap: C$46.1 million
Share price: C$1BP Silver is an exploration company focused on its flagship Cosuño silver project in Bolivia.
Covering approximately 3,375 hectares, the project hosts a 10.5 square kilometer alteration zone with at least four primary exploration targets identified within the southern area.
Shares of BP Silver began the year at C$0.62 before tracking the price of silver higher to hit C$0.93 on January 29. BP Silver released assay results from the first two holes of its Phase I drill program at Cosuño on February 2. Highlights from the results include 29 meters at 56 grams per metric ton (g/t) silver and 0.28 g/t gold.
On February 27, the company announced assay results from the final eight holes of the 11 hole drill program at Cosuño. This time, high grades were on display, with one hole delivering 600.4 g/t silver over 5 meters; that includes an intersection of 1,655 g/t silver over 1 meter.
BP Silver's stock value reached a year-to-date high of C$1.32 on March 2.
2. Highlander Silver (TSX:HSLV)
Year-to-date gain: 41.3 percent
Market cap: C$1.49 million
Share price: C$7.63Highlander Silver has a portfolio of precious metal assets in Latin America. In Mexico, the company operates the Mercedes gold-silver mine. In Peru, it is advancing the Corani silver project and the San Luis gold-silver project. Late last year, the company announced a merger with Bear Creek Mining; it was completed in February.
Shares of Highlander kicked off the year trading at C$5.46, and by January 28 had hit C$7.89.
On January 27, Highlander announced a US$40 million strategic investment by Eric Sprott through the purchase of common shares in the company. Its other major shareholders include the Augusta Group and Lundin family.
“The additional capital will allow us to accelerate growth plans within our portfolio, which includes the bonanza grade San Luis gold-silver project, one of the highest M&I resource grade projects in either the gold or silver sectors, and one of the largest permitted primary silver deposits in the world in the Corani silver project after the closing of the previously announced combination with Bear Creek Mining," stated Daniel Earle, president and CEO of Highlander.
Highlander's share price reached its highest year-to-date value of C$10.42 on March 2.
3. Honey Badger Silver (TSXV:TUF)
Year-to-date gain: 28.95 percent
Market cap: C$31.93 million
Share price: C$0.285Honey Badger Silver is an exploration-stage company with a large portfolio of greenfield and brownfield projects in Canada's Northwest Territories, as well as Yukon and Nunavut.
This includes the newly required PC silver project in the Northwest Territories.
PC is a permitted underground silver-zinc-lead project that hosts a large, high-grade historical resource base with significant existing underground and development infrastructure. In late March, Honey Badger closed on an C$11.5 million private placement to fund the costs associated with the acquisition.
Shares of Honey Badger reached a year-to-date high of C$0.32 on January 23.
4. First Majestic Silver (TSX:AG)
Year-to-date gain: 23.26 percent
Market cap: C$14.19 billion
Share price: C$28.77First Majestic Silver is the world’s second biggest silver miner by market cap.
It operates four mines in Mexico: Durango's San Dimas silver-gold mine, the Santa Elena silver-gold mine in Sonora, the La Encantada silver mine in Coahuila and the Los Gatos silver mine in Chihuahua. Los Gatos, in which Japan's Dowa Holdings (TSE:5714,OTCPL:DWMNF) owns a 30 percent share, also produces zinc, lead and gold as by-products.
Additionally, First Majestic mints and sells silver bullion from its First Mint facility in Nevada, US.
On January 15, the company reported that its 2025 silver production came in at 15.4 million ounces.
First Majestic's production guidance for 2026 is set at 13 million to 14.4 million ounces of silver, with silver equivalent all-in sustaining costs at US$26.15 to US$27.91 per ounce.
First Majestic’s stock value rose from C$22.06 to a year-to-date high of C$43.64 on February 27.
5. Silvercorp Metals (TSX:SVM)
Year-to-date gain: 21.64 percent
Market cap: C$2.95 billion
Share price: C$14.28Silvercorp Metals is the world's fourth biggest silver-mining company by market cap. It operates two silver mines in China: the Ying Mining District in Henan and the GC mine in Guangdong.
In its operations report for its third fiscal quarter of 2026, the company reported total silver production for the quarter of 1.9 million ounces, a 4 percent decrease from the same period last year.
Silvercorp also shared that it is constructing the Kuanping project as a satellite deposit for the Ying mine, with minor ore production to begin in June. The company released its latest quarterly revenue figures on February 9, outlining US$126.1 million, up 51 percent over the same period last year.
After starting the year with a share price of C$11.45, the company had climbed to C$15.74 on January 16. Shares of Silvercorp rose to a year-to-date high of C$18.96 on February 27.
Don’t forget to follow us @INN_Resource for real-time news updates!
Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.
- International Graphite Eyes European Supply Gap with Alkeemia JV (2026-04-01)
Speaking to the Investing News Network, International Graphite (ASX:IG6,OTCPL:IGRPF) Managing Director Andrew Worland said nearly all graphite consumed in Europe is currently sourced from China.
“That’s where the opportunity is,” he said, noting strong interest from European customers seeking to diversify supply and International Graphite growing at 3 to 5 percent per annum.
International Graphite is targeting this gap through a joint venture with Alkeemia, which seeks to build a significant graphite-processing facility in Italy.
Under the joint venture, Alkeemia will own 51 percent, while International Graphite will hold the remaining 49 percent. The companies will retain a 50/50 profit.
International Graphite is currently advancing technical and commercial workstreams, including site selection, infrastructure planning and capital cost estimates. It is also developing an economic model for the project.
Worland said the project will focus on processing graphite concentrate sourced from existing producers, rather than developing new mining operations.
Near-term milestones include securing commercial agreements by May, and reaching a final investment decision by June. International Graphite is also engaging with potential customers to establish offtake agreements to support development.
“We think we’ve got an incredible value. We’ve got a different approach than most of our graphite peers who are focused on mining primarily,” Worland added. “Our focus is very much on near-term cashflow, low-capital projects and efficient use of shareholder funds with a US$10 million to 12 million enterprise value at this point.”
The managing director said that more updates on these catalysts are expected over the next six to 12 weeks.
Watch the full interview with International Graphite Managing Director Andrew Worland above.
- Crypto Market Update: CoinShares Makes Nasdaq Debut via SPAC Deal (2026-04-01)
Here's a quick recap of the crypto landscape for Wednesday (April 1) as of 11:00 a.m. UTC.
Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrency market news.
Bitcoin (BTC) was priced at US$68,508.40, up by 1.5 percent over the last 24 hours.
Ether (ETH) was priced at US$2,131.26, up by 2.4 percent over the last 24 hours.
Altcoin price update
- XRP (XRP) was priced at US$1.35, up by 1.6 percent over 24 hours.
- Solana (SOL) was trading at US$83.34, trading 1.3 percent higher over 24 hours.
Today's crypto news to know
CoinShares debuts on Nasdaq in SPAC deal
European digital asset manager CoinShares (NASDAQ:CSHR) has begun trading on Nasdaq after completing its merger with a special purpose acquisition company (SPAC), marking its formal entry into US capital markets.
The deal values the firm at about US$1.2 billion and brings roughly US$6 billion in assets under management into closer competition with major US players. The company is positioning the listing as a continuation of its plans to expand beyond standard crypto exchange-traded funds into more complex, higher-margin products.
The company already controls a significant share of Europe’s digital asset exchange-traded product market, and has been scaling its US footprint following its acquisition of Valkyrie Funds.
DOJ charges 10 in crypto manipulation scheme
US prosecutors have charged 10 individuals linked to four market-making firms in an alleged cryptocurrency price manipulation operation spanning multiple jurisdictions.
Authorities say the group artificially inflated trading volumes and token prices before offloading assets onto unsuspecting investors, in classic pump-and-dump fashion.
The case stems in part from a Federal Bureau of Investigation sting operation that used a government-created token to expose manipulation services. Several defendants have already been extradited and appeared in US court, while others have pleaded guilty or face sentencing.
More than US$1 million in crypto has been seized so far, with further asset recovery efforts ongoing.
Australia imposes bank-grade rules on crypto platforms
Australia has enacted sweeping new legislation that brings crypto platforms fully into its financial services regime.
Exchanges and custody providers will now be required to obtain an Australian Financial Services License and comply with standards similar to traditional financial institutions.
The law introduces strict requirements around capital adequacy, custody safeguards, governance and consumer disclosures. It also creates formal categories for digital asset platforms and tokenized custody services, placing them under the supervision of the corporate regulator. Smaller operators are given limited exemptions, but most firms will face significantly higher compliance costs and operational scrutiny.
Don't forget to follow us @INN_Technology for real-time news updates!
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
- Perpetua Closer to Securing US Backing for Multibillion-Dollar Stibnite Project (2026-04-01)
Perpetua Resources (TSX:PPTA,NASDAQ:PPTA) moved closer to securing US government backing for its Stibnite gold and antimony project in Idaho after the Export-Import Bank advanced a proposed US$2.7 billion loan to Congress for review.
The proposed package includes a direct loan of about US$2.2 billion that covers capitalized interest and fees. Perpetua said a final vote is expected shortly after the review period concludes.
If approved, the financing, combined with US$714 million in cash on hand at year-end, would fully cover the project’s estimated US$2.576 billion capital cost as outlined in an updated technical report, as well as ongoing exploration and corporate costs.
“Today’s decision marks the final phase of EXIM approval,” CEO Jon Cherry said in a press release. “We’ve worked diligently with US EXIM for over two years on a financing solution aimed at strengthening America’s supply chains, creating jobs right here at home, and fortifying national security.”
The company said the development keeps it on track for a final investment decision later this year. Potential loan drawdowns are also included in the second half of 2026, subject to approval and completion of definitive documentation.
According to figures published alongside the confirmation, the updated economics of the project also point to stronger returns driven primarily by higher gold price assumptions.
At a long-term gold price of US$3,250 per ounce, the project carries an after-tax net present value of US$3.5 billion at a 5 percent discount rate and an internal rate of return of 23.5 percent. At US$4,500 gold, the after-tax NPV rises to US$6.1 billion, with an IRR of 32.3 percent.
The revised technical report incorporates engineering completed during 2025, with the project estimated to be approximately 45 percent engineered as of year-end.
Perpetua has already advanced key elements of project execution. Early works construction began in October 2025, following receipt of all major permits and the posting of construction-stage financial assurance with federal and state agencies.
The Stibnite project is being positioned as a strategic domestic source of both gold and antimony, the latter classified as a critical mineral in the US due to its role in defense systems and energy technologies.
The project is expected to be the only domestic mined source of antimony, aligning with EXIM’s “Make More in America” program objectives.
Financing efforts for the project have also been supported by private capital. Last year, Perpetua raised more than US$850 million in equity, including a US$255 million strategic investment from Agnico Eagle Mines (TSX:AEM,NYSE:AEM) and JPMorganChase.
The Canadian miner also committed US$180 million for common shares alongside warrants and will collaborate with Perpetua through a technical and exploration advisory committee
Don’t forget to follow us @INN_Resource for real-time news updates!
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
- Blackstone Raises Record US$6.3 Billion for Largest Life Sciences Fund (2026-04-01)
Blackstone (NYSE:BX) has raised US$6.3 billion for its latest life sciences fund, the largest private vehicle dedicated to the sector.
The fund, Blackstone Life Sciences VI (BXLS VI), was oversubscribed and closed at its hard cap, about 40 percent larger than its predecessor, which raised US$4.6 billion in 2020.
The vehicle continues Blackstone’s strategy of funding individual drug assets rather than taking equity stakes in companies, targeting programs in advanced clinical stages with defined paths to market.
“Our partnerships with global leaders have produced 34 regulatory approvals of innovative medicines and devices,” said Nicholas Galakatos, global head of life sciences at Blackstone.
“This track record highlights how we work successfully with industry trailblazers to help bring their most important products to patients around the world.”
Since launching the platform in 2018, Blackstone has deployed capital across a series of large transactions tied to late-stage assets.
In 2020, it entered a US$2 billion collaboration with Alnylam Pharmaceuticals to fund RNA interference therapies. In 2024, it committed US$750 million to Moderna (NASDAQ:MRNA) to support development of mRNA-based influenza vaccines.
More recently, the firm has continued to structure deals around Phase 3 programs. It agreed to provide US$400 million alongside Johnson & Johnson (NYSE:JNJ) to advance the leukemia drug bleximenib, and another US$400 million to Teva (NYSE:TEVA) to support development of duvakitug, a monoclonal antibody targeting inflammatory diseases.
Blackstone has also used royalty-based financing structures to fund oncology pipelines. In 2025, it committed US$700 million to support development of Merck's (NYSE:MRK) sacituzumab tirumotecan, an antibody-drug conjugate being tested across multiple cancers, in exchange for a share of future revenues.
The platform has generated exits as well. Last year, Blackstone sold Anthos Therapeutics to Novartis (NYSE:NVS) for US$3.1 billion, marking one of its largest realized transactions in the space.
Several therapies backed by the firm have reached the market, including Alnylam’s Amvuttra, Novartis’ Leqvio, and AbbVie (NYSE:ABBV) and Johnson & Johnson’s Imbruvica.
Blackstone said its life sciences platform has achieved an 86 percent regulatory approval rate for Phase 3 assets, exceeding industry averages. The BXLS platform managed about US$15 billion in assets as of the end of 2025.
Don’t forget to follow @INN_LifeScience for real-time updates!
Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.
